Rare insights into cancer biology - PubMed (original) (raw)
Review
. 2014 May 15;33(20):2547-56.
doi: 10.1038/onc.2013.222. Epub 2013 Jul 1.
Affiliations
- PMID: 23812428
- DOI: 10.1038/onc.2013.222
Review
Rare insights into cancer biology
J Adam et al. Oncogene. 2014.
Abstract
Cancer-associated mutations have been identified in the metabolic genes succinate dehydrogenase (SDH), fumarate hydratase (FH) and isocitrate dehydrogenase (IDH), advancing and challenging our understanding of cellular function and disease mechanisms and providing direct links between dysregulated metabolism and cancer. Some striking parallels exist in the cellular consequences of the genetic mutations within this triad of cancer syndromes, including accumulation of oncometabolites and competitive inhibition of 2-oxoglutarate-dependent dioxygenases, particularly, hypoxia-inducible factor (HIF) prolyl hydroxylases, JmjC domain-containing histone demethylases (part of the JMJD family) and the ten-eleven translocation (TET) family of 5methyl cytosine (5mC) DNA hydroxylases. These lead to activation of HIF-dependent oncogenic pathways and inhibition of histone and DNA demethylation. Mutations in FH, resulting in loss of enzyme activity, predispose affected individuals to a rare cancer, hereditary leiomyomatosis and renal cell cancer (HLRCC), characterised by benign smooth muscle cutaneous and uterine tumours (leiomyomata) and an aggressive form of collecting duct and type 2 papillary renal cancer. Interestingly, loss of FH activity results in the accumulation of high levels of fumarate that can lead to the non-enzymatic modification of cysteine residues in multiple proteins (succination) and in some cases to their disrupted function. Here we consider that the study of rare diseases such as HLRCC, combining analyses of human tumours and cell lines with in vitro and in vivo murine models has provided novel insights into cancer biology associated with dysregulated metabolism and represents a useful paradigm for cancer research.
Similar articles
- The emerging role of fumarate as an oncometabolite.
Yang M, Soga T, Pollard PJ, Adam J. Yang M, et al. Front Oncol. 2012 Jul 31;2:85. doi: 10.3389/fonc.2012.00085. eCollection 2012. Front Oncol. 2012. PMID: 22866264 Free PMC article. - Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
Xiao M, Yang H, Xu W, Ma S, Lin H, Zhu H, Liu L, Liu Y, Yang C, Xu Y, Zhao S, Ye D, Xiong Y, Guan KL. Xiao M, et al. Genes Dev. 2012 Jun 15;26(12):1326-38. doi: 10.1101/gad.191056.112. Epub 2012 Jun 7. Genes Dev. 2012. PMID: 22677546 Free PMC article. - The role of metabolic enzymes in mesenchymal tumors and tumor syndromes: genetics, pathology, and molecular mechanisms.
Schaefer IM, Hornick JL, Bovée JVMG. Schaefer IM, et al. Lab Invest. 2018 Apr;98(4):414-426. doi: 10.1038/s41374-017-0003-6. Epub 2018 Jan 16. Lab Invest. 2018. PMID: 29339836 Review. - Fumarate hydratase deficiency and cancer: activation of hypoxia signaling?
Ratcliffe PJ. Ratcliffe PJ. Cancer Cell. 2007 Apr;11(4):303-5. doi: 10.1016/j.ccr.2007.03.015. Cancer Cell. 2007. PMID: 17418405 - Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases.
Kaelin WG Jr. Kaelin WG Jr. Cold Spring Harb Symp Quant Biol. 2011;76:335-45. doi: 10.1101/sqb.2011.76.010975. Epub 2011 Nov 16. Cold Spring Harb Symp Quant Biol. 2011. PMID: 22089927 Free PMC article. Review.
Cited by
- Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
Robey RB, Weisz J, Kuemmerle NB, Salzberg AC, Berg A, Brown DG, Kubik L, Palorini R, Al-Mulla F, Al-Temaimi R, Colacci A, Mondello C, Raju J, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Hamid RA, Williams GP, Lowe L, Meyer J, Martin FL, Bisson WH, Chiaradonna F, Ryan EP. Robey RB, et al. Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S203-31. doi: 10.1093/carcin/bgv037. Carcinogenesis. 2015. PMID: 26106140 Free PMC article. Review. - The Succinated Proteome of FH-Mutant Tumours.
Yang M, Ternette N, Su H, Dabiri R, Kessler BM, Adam J, Teh BT, Pollard PJ. Yang M, et al. Metabolites. 2014 Aug 7;4(3):640-54. doi: 10.3390/metabo4030640. Metabolites. 2014. PMID: 25105836 Free PMC article. - The p23 co-chaperone is a succinate-activated COX-2 transcription factor in lung adenocarcinoma tumorigenesis.
Yu Z, Peng Y, Gao J, Zhou M, Shi L, Zhao F, Wang C, Tian X, Feng L, Huo X, Zhang B, Liu M, Fang D, Ma X. Yu Z, et al. Sci Adv. 2023 Jun 30;9(26):eade0387. doi: 10.1126/sciadv.ade0387. Epub 2023 Jun 30. Sci Adv. 2023. PMID: 37390202 Free PMC article. - Metabolic Rewiring and the Characterization of Oncometabolites.
Beyoğlu D, Idle JR. Beyoğlu D, et al. Cancers (Basel). 2021 Jun 10;13(12):2900. doi: 10.3390/cancers13122900. Cancers (Basel). 2021. PMID: 34200553 Free PMC article. Review. - Metabolic Plasticity of Tumor Cell Mitochondria.
Cannino G, Ciscato F, Masgras I, Sánchez-Martín C, Rasola A. Cannino G, et al. Front Oncol. 2018 Aug 24;8:333. doi: 10.3389/fonc.2018.00333. eCollection 2018. Front Oncol. 2018. PMID: 30197878 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous